ARTICLE | Clinical News
VIAject regulatory update
August 30, 2010 7:00 AM UTC
Biodel said manufacturing partner Albany Molecular Research Inc. (NASDAQ:AMRI, Albany, N.Y.) received a warning letter from FDA related to a Burlington, Mass., facility that produces finished product...